3
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Human papillomaviruses, cervical cancer and the Developing World

Pages 453-463 | Received 05 Jul 1995, Accepted 12 Jul 1995, Published online: 15 Nov 2016

REFERENCES

  • Alloub, M. I., Barr, B. B. B., McLaren, K. M., Smith, I. W., Bunney, M. B. & Smart, G. E. (1989). Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. British Medical Journal, ii, 153–156.
  • Andersson-Ellstrom, A., Dillner, J., Hagmar, B., Schiller, J. & Forssman, L. (1994). No serological evidence for the non-sexual spread of HPV 16. Lancet, ii, 1331–1335.
  • Anwar, K., Inizuka, M., Shiraishi, T. & Nakakuki, K. (1991). Detection of HPV DNA in neoplastic and non-neoplastic cervical specimens from Pakistan and Japan by non-isotopic in situ hybridization. International Journal of Cancer, 47, 675–680.
  • Bauer, H. M., Ting, Y., Greer, C. E., Chambers, J. C., Tashiro, C. J., Chimera, J., Reingold, A. & Manos, M. M. (1991). Genital human papillomavirus infection in female university students as determined by a PCR-based method. Journal of the American Medical Association, 265, 427–477.
  • Beral, V., Hannaford, P. & Kay, C. (1988). Oral contraceptive use and malignancies from the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study. Lancet, ii, 1331–1335.
  • Bonnez, W., da Rin, C., Rose, R. C. & Reichman, R. C. (1991). Use of human papillomavirus type 11 virions in an elisa to detect specific antibodies in humans with condylomata acuminata. Journal of General Virology, 72, 1343–1347.
  • Boyd, J. T. & Doll, R. (1964). A study of the aetiology of carcinoma of the cervix uteri. British Journal of Cancer, 18, 419–435.
  • Brandsma, J. L. (1994). Animal models for HPV vaccine development. Papillomavirus Report, 5, 105–111.
  • Butterworth, C. E., Hatch, K., Macaluso, M., Cole, P., Sauberlich, H. E., Soong, S. J., Borst, M. & Baker, V. V. (1992). Folate deficiency and cervical dysplasia. Journal of the American Medical Association, 267, 528–533.
  • Campo, M. S., Grindlay, G. J., O'Niel, B. W., Chandrachud, L. M., McGarvie, G. M. & Jarrett, W. F. (1993). Prophylactic and therapeutic vaccination against a mucosal papillomavirus. Journal of General Virology, 74, 945–953.
  • Campo, M. S., Moor, M. H., Jarrett, W. F. H. & Laird, H. M. (1980). A new papillomavirus associated with alimentary cancer in cattle. Nature, 286, 180–182.
  • Christensen, N. D., Hopfl, R., Diangelo, S. L., Cladel, N. M., Patrick, S. D., Welsh, P. A., Budgeon, L. R., Reed, C. A. & Kreider, J. W. (1994). Assembled baculovirus-expressed human papillomavirus type 11 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. Journal of General Virology, 75, 2271–2276.
  • Coleman, N., Birley, H. D. L., Renton, A. M., Hanna, N. F., Ryait, B. M., Byrne, M., Taylor-Robinson, D. & Stanley, M. (1994). Immunological events in regressing genital warts. American Journal of Clinical Pathology, 102, 768–774.
  • Cromme, F. V., Airey, J., Heemels, M. T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J. & Walboomers, J. M. (1994). Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. Journal of Experimental Medicine, 179, 335–340.
  • Cullen, A. P., Reid, R., Campion, M. & Lorincz, A. T. (1991). Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Journal of Virology, 65, 606–612.
  • Daling, J. R. & Sherman, K. J. (1992). Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. In The Epidemiology of Human Papillomavirus and Cervical Cancer, eds Munoz, N., Bosch, F. X., Shah, K. V. & Meheuz, A. pp. 223–241. Lyons: IARC Scientific.
  • Demetrick, D. J., Masafumi, I., Lester, W. A., Kingma, I., Duggan, M. A. & Leendert, C. P. (1990). Human papillomavirus type 16 associated with oral squamous carcinoma in a cardiac transplant recipient. Cancer, 66, 1726–1731.
  • De Villiers, E. M. (1989). Heterogeneity of the human papillomavirus group. Journal of Virology, 63, 4898–4903.
  • De Villiers, E. M., Wagner, D., Schneider, A., Wesch, H., Munz, F., Miklaw, H. & zur Hauzen, H. (1992). Human papillomavirus DNA in women with and without cytological abnormalities: results of a five year follow-up study. Gynecologic Oncology, 44, 33–39.
  • Durst, M., Kleinheinz, A., Hotz, M. & Gissman, L. (1985). The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology, 66, 1515–1522.
  • Dyson, N., Howley, P. M., Munger, K. & Harlow, E. (1989). The human papillomavirus 16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science, 243, 934–936.
  • Ellis, J. R. M., Keating, P. J., Baird, J., Hounsell, E. F., Renouf, D. V., Rowe, M., Hopkins, D., Duggan-Keen, M. F., Bartholomew, J. S., Young, L. S. & Stern, P. L. (1995). The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature Medicine, 1, 464–470.
  • Ferency, A., Mitao, M., Nagai, N., Silverstein, S. J. & Crum, C. P. (1985). Latent papillomavirus and recurring genital warts. New England Journal of Medicine, 313, 784–788.
  • Franco, E. L. (1991). The sexually transmitted diseases model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology, 2, 98–106.
  • Fraumeni, J. F., Lloyd, J. W., Smith, E. M. & Wagoner, J. K. (1969). Cancer mortality amongst nuns: role of marital status in etiology of neoplastic disease in women. Journal of the National Cancer Institute, 42, 455–468.
  • Gravitt, P. E. & Manos, M. M. (1992). Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. In The Epidemiology of Human Papillomavirus and Cervical Cancer, eds Munoz, N., Bosch, F. X., Shah, M. V. & Meheus, A. pp. 223–241. Lyons: IARC Scientific.
  • Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., Tenorio, F., de Britton, R. C., Gaiton, E., Garcia, M. & Rawls, W. E. (1989). Invasive cervical cancer and smoking in Latin America. Journal of the National Cancer Institute, 81, 205–211.
  • Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., Tenorio, F., de Britton, R. C., Gaitan, E., Garcia, M. & Rawls, W. E. (1990). Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high risk population. Cancer, 65, 380–386.
  • Hilders, C. G. J. M., Houbiers, J. G. A., van Ravenswaay-Claasen, H. H., Veldhuizen, R. W. & jan Fleuren, G. (1993). Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Laboratory Investigation, 69, 651–659.
  • Inman, G. J., Cook, I. D. & Lau, R. K. W. (1993). Human papillomaviruses, tumour suppressor genes and cervical cancer. International Journal of STD and AIDS, 4, 128–134.
  • Jochmus-Kudielka, I., Schneider, A., Braun, R., Kimmig, R., Koldovsky, U., Schneweis, K. E., Seedorf, K. & Gissmann, L. (1989). Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. Journal of the National Cancer Institute, 81, 1698–1704.
  • Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R. & Schiller, J. T. (1994). A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute, 86, 494–498.
  • Kjaer, S. K., de Villiers, E. M., Caglayan, H., Svare, E., Haugaard, B. J., Engholm, G., Christensen, R. B., Moller, K. A., Poll, P. & Jensen, H. (1993). Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)—a second look. British Journal of Cancer, 67, 830–837.
  • Kjaer, S. K., Engholm, G., Teisen, C., Haugaard, B. J., Lynge, E., Christensen, R. B., Moller, K. A., Jensen, H., Poll, P., Vestergaard, B. F., De Villiers, E. M. & Jensen, O. M. (1990). Risk factors for cervical human papillomavirus and human herpes simplex virus infections in Greenland and Denmark: a population-based survey. American Journal of Epidemiology, 131, 669–682.
  • Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, P. A. J., Beckman, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D. & Kiviat, N. B. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New England Journal of Medicine, 327, 1272–1278.
  • Ley, C., Bauer, H. M., Reingold, A., Chambers, J. C., Tashiro, C. J. & Manos, M. M. (1991). Determinants of genital human papillomavirus infection in young women. Journal of the National Cancer Institute, 83, 977–1003.
  • Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H. & Hong, W. K. (1993). Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine, 328, 15–20.
  • Matsukura, T., Koi, S. & Sugase, M. (1989). Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology, 172, 63–72.
  • Meyers, C., Frattini, M. G., Hudson, J. B. & Laimins, L. A. (1992). Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science, 257, 971–973.
  • Morrison, A. S. (1992). Screening in Chronic Disease, 2nd Edn. Monographs in Epidemiology and Statistics No. 19. Oxford: Oxford University Press.
  • Munger, K., Phelps, W. C., Bubb, V., Howley, P. M. & Schlegel, R. (1986). The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. Journal of Virology, 63, 4417–4421.
  • Munoz, N., Bosch, F. D., Sanjose, S., Tafur, L., Izarugaza, I., Gili, M., Viladiu, P., Navaro, C., Martos, C., Ascunce, N., Gonzales, L. C., Kaldor, J. M., Guerrero, E., Lorincz, A., Santamaria, M., Alonzo de Ruiz, P., Aristizabal, N. & Shah, K. V. (1992). The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Columbia and Spain. International Journal of Cancer, 52, 743–749.
  • Ogunbiyi, O. A., Scholefield, J. H., Raftery, A. T., Smith, J. H. F., Duffey, S., Sharp, F. & Rogers, K. (1994). Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. British Journal of Surgery, 81, 365–367.
  • Parent-Duchatelet, A. J. B. (1837). De la Prostitution dans la Ville de Paris. Brussels: Establissement Encyclographique.
  • Parkin, D. M. (1991). Screening for cervix cancer in developing countries. In Cancer Screening, eds Miller, A. B., Chamberlain, J., Day, N. E., Hakama, M. & Prorok, P. C. pp. 184–198. Cambridge: Cambridge University Press.
  • Parkin, D. M., Pisani, P. & Ferlay, J. (1993). Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer, 54, 594–606.
  • Pater, A., Bayatpour, M. & Pater, M. M. (1990). Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. American Journal of Obstetrics and Gynecology, 162, 1099–1103.
  • Ponten, J., Adami, H.-O., Bergstrom, R., Dillner, J., Friberg, L.-G., Gustafsson, L., Miller, A. B., Parkin, D. M., Sparen, P. & Trichopoulos, D. (1995). Strategy for global control of cervical cancer. International Journal of Cancer, 60, 1–26.
  • Prabhakar, H. K. (1992). Strategy for control of cervical cancer in India. Acta Universitatis Tamperensis (Series A), 334.
  • Rous, P. & Kidd, J. G. (1936). The carcinogenic effect of a virus upon tarred skin. Science, 83, 468–469.
  • Rymark, P., Forslund, O., Hansson, B. G. & Lindholm, K. (1993). Genital HPV infection not a local but a regional infection: experience from a female teenage group. Genitourinary Medicine, 69, 18–23.
  • Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. R., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., Stanton, C. K. & Manos, M. M. (1993). Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute, 85, 958–964.
  • Schiffman, M. H., Hauer, H. M., Lorincz, A. T., Manos, M. M., Byrne, J. C., Glass, A. G., Cadell, D. M. & Howley, P. M. (1991). Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus infection. Journal of Clinical Microbiology, 29, 573–577.
  • Schiffman, M. H., Haley, N. J., Felton, J. S., Andrews, A. W., Kaslow, R. A., Lancaster, W. D., Kurman, R. J., Brinton, L. A., Lannom, L. B. & Hoffman, D. (1987). Biochemical epidemiology of cervical neoplasia: measuring cigarette constituents in the cervix. Cancer Research, 47, 3886–3888.
  • Schneider, A. & Koutsky, L. A. (1992). Natural history and epidemiological features of genital HPV infection. In The Epidemiology of Human Papillomavirus and Cervical Cancer, eds Munoz, N., Bosch, F. X., Shah, K. V. & Meheus, A. pp. 25–52. Lyons: IARC Scientific.
  • Schneider, A. & Shah, K. (1989). The role of vitamins in the etiology of cervical neoplasia: an epidemiological review. Archives of Gynecology and Obstetrics, 246, 1–13.
  • Semba, R. D. (1994). Vitamin A, immunity and infection. Clinical Infectious Diseases, 19, 489–499.
  • Sherman, M. E., Schiffman, M. H., Lorincz, A. T., Manos, M. M., Scott, D. R., Kuman, R. J., Kiviat, N. B., Stoler, M., Glass, A. G. & Rush, B. B. (1994). Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. American Journal of Clinical Pathology, 102, 182–187.
  • Singh, V., Sehgal, A. & Luthra, U. K. (1992). Screening for cervical cancer by direct inspection. British Medical Journal, ii, 534–535.
  • Ter Meulen, J., Eberhradt, H. C., Luande, J., Mgaya, H. N., Chang-Claude, J., Mtiro, H., Mhina, M., Kashaija, P., Ockert, S., Yu, X., Meinhardt, G., Gissmann, L. & Pawlita, M. (1992). Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. International Journal of Cancer, 51, 515–521.
  • Tsang, S. S., Li, G. & Stich, H. F. (1988). Effect of retinoic acid on bovine papillomavirus (BPV) DNA-induced transformation and number of BPV DNA copies. International Journal of Cancer, 42, 94–98.
  • Van den Brule, A. J., Class, E. C., du Maine, M., Melcherse, W. J., Helmerhorst, T., Quint, W. G., Lindeman, J., Meijer, C. J. & Walboomers, J. M. (1989). Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus in cervical scrapes and biopsies. Journal of Medical Virology, 29, 20–27.
  • Van Ranst, M., Kaplan, J. B. & Burk, R. D. (1992). Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. Journal of General Virology, 73, 2653–2660.
  • Villa, L. L. & Franco, E. L. F. (1989). Epidemiological correlates of cervical neoplasia in asymptomatic women in Brazil. Journal of the National Cancer Institute, 81, 332–340.
  • Wank, K. & Thomssen, C. (1992). High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature, 352, 723–725.
  • Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76–79.
  • Zeltner, R., Borenstein, L. A., Wettstein, F. O. & Iftner, T. (1994). Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits. Journal of Virology, 68, 3620–3630.
  • Zhou, J., Sun, X. Y., Stenzel, D. J. & Frazer, I. H. (1991). Expression of vaccinia recombinant HPV16 L1 and L2 ORF protein in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology, 185, 251–257.
  • Zur Hausen, H. (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184, 9–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.